Samarth Kulkarni - Oct 15, 2021 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role
Chief Executive Officer, Director
Signature
/s/ Michael Esposito, attorney-in-fact
Stock symbol
CRSP
Transactions as of
Oct 15, 2021
Transactions value $
$59,730
Form type
4
Date filed
10/18/2021, 08:00 PM
Previous filing
Sep 3, 2021
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRSP Common Shares Options Exercise $59.7K +33K +17.65% $1.81* 220K Oct 15, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRSP Stock Option (Right to Buy) Award $0 +43K $0.00 43K Oct 15, 2021 Common Shares 43K $97.00 Direct F1
transaction CRSP Stock Option (Right to Buy) Options Exercise $0 -33K -30.28% $0.00 76K Oct 15, 2021 Common Shares 33K $1.81 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on October 15, 2021 with respect to 43,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 15, 2021.
F2 This option was granted on September 10, 2015 with respect to 321,712 Common Shares with 120,640 of the shares vested on August 1, 2016, the first anniversary of employment commencement, and the remainder vested in equal 36 monthly installments thereafter.